Technology | Cardiovascular Business | February 07, 2017

Innovaccer Launches MIPS Reporting and Performance Optimization Platform

Providers can calculate any MIPS registry quality measure using data from disparate sources to improve Composite Performance Scores

Innovaccer, MIPS Platform, reporting and performance optimization, Datashop

February 7, 2017 — Healthcare analytics company Innovaccer Inc. announced the launch of its holistic MIPS Platform designed to enable providers to deliver better clinical outcomes. The platform does this by helping providers monitor performances, understand population, efficiently manage data and easily submit it to the Centers for Medicare and Medicaid Services (CMS).

The platform has the capability to ingest clinical, claims, ADT, scheduling, immunization, medication and labs data from disparate sources in one single longitudinal patient view. Through intuitive dashboards in the platform, providers can calculate any MIPS (Merit-Based Incentive Payment System) registry quality measure or eCQM, track and improve group/provider's MIPS Composite Performance Score.

MIPS Platform is a part of Innovaccer's existing platform Datashop. It has the list of all the measures that are used across the multiple performance measures, including measures required for quality, advancing care information and clinical practice improvement activities. In addition to this, description for every measure has been provided to help the users understand them easily.

MIPS is a part of the Quality Payment Program rolled out by CMS. Implemented on Jan. 1, it combines the existing programs such as the Physician Quality Reporting System (PQRS), Meaningful Use and the Value-based Modifier into one performance payment system.

Innovaccer’s MIPS Platform also educates the care teams about the program, requirements and care opportunities, reducing training requirements. With a simple point-and-click interface, the platform can help both MIPS and MIPS alternative payment models (APMs) to adapt quickly to new regulations and secure maximum reimbursements.

For more information: www.innovaccer.com


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now